Your Battery Pack Supply Agreement May Not Actually Secure Cell Allocation

A supply agreement secures cell allocation only when it does four things at once: it names the cell by manufacturer and part number, it places the buyer inside a defined priority tier with a stated allocation method, it turns the rolling forecast into something the supplier is contractually bound to act on, and it ties a remedy to a shortfall. Everything else in the document — commercially reasonable efforts, general capacity commitments, pack-brand assurances — expresses intent rather than allocation.

Sit down at the table with me. There is a redlined draft between us, third revision, tabs down the right edge. On the left of page four: "Supplier shall use commercially reasonable efforts to meet Buyer's forecasted requirements." It reads well. Before you highlight it, ask one question: when the cell maker cuts your supplier's allocation, what does that sentence force them to do?

You already know the answer, and so does the person on the other end of the call. I am not a lawyer and I do not grade clauses on whether a court would enforce them. I read for behavior — what the supplier's planner will actually do on the day the cell maker's allocation letter lands in their inbox. That is a different review than the one legal runs, and it has to happen before signature, not after the first missed delivery.

Priority is a tier, not a sentence

Open the agreement to the allocation clause and read what it points at. Real priority language names something: a tier, a set of customers, a product family. If your supplier's clause defines priority as the buyers who sit in a named first tier backed by two named OEM customers and a named platform, you now know exactly where you land — and if you are not on that list, best-efforts language is the language of a customer who gets served last.

The problem is that both versions sound identical in a summary. "Supplier will prioritize Buyer" and "Supplier will use commercially reasonable efforts to meet Buyer's requirements" both read as commitments in a slide deck. Only one of them tells a planner what to do when there are two orders and one pallet of cells.

So the read is mechanical. Find the clause. Find the nouns. If the clause contains no named competitor, no named customer tier, and no ranked list, you have not bought priority. You have bought a sentence.

The forecast clause is not the allocation clause

There is a specific confusion that costs buyers real money, and it usually happens in the negotiation rather than in the shortage. The buyer says: we are giving you a twelve-month rolling forecast with the first three months firm. That has to count for something.

It counts for planning. It does not count for allocation unless the agreement states how the supplier must treat that forecast. A rolling forecast is a number the supplier receives. The contract is what decides whether that number obligates them to reserve cells, to place purchase orders against it, or to set aside capacity equal to it. A rolling forecast becomes commercially useful for allocation only at the moment the supply agreement says what the supplier owes you in return for it.

Forecast accuracy and forecast horizon are separate from priority. An accurate forecast attached to a soft allocation clause still loses to a loose forecast sitting inside a hard tier. Buyers trade those two things against each other in the room as if they were the same currency. They are not.

What to look for instead is language that converts forecast into obligation. Something like: supplier shall place binding cell purchase orders sufficient to cover one hundred percent of the first three months of the rolling forecast. Or: supplier shall reserve capacity equal to buyer's forecasted volume. That is a forecast clause with teeth. Anything short of it is an information exchange with a polite tone.

Where the cell's name belongs

Allocation follows the cell, not the pack brand.

That one line rearranges the entire review. You are not really buying packs from a pack company; you are renting a position inside a cell maker's allocation, and the pack assembler is the intermediary. If your robot's charge profile, thermal design, and BMS configuration were validated against one specific cell, that cell's part number belongs in the agreement, not implied by the pack brand on the cover page.

I have watched buyers sign off on a generic substitution right — supplier may substitute equivalent cells — because it sounded like flexibility. What it hands the supplier is a free move. If they cannot get the validated cell, they ship a different one, and now your validation report describes a cell you are not running. If substitution is allowed at all, it needs an approval step and a re-validation window, both written.

There is a real tradeoff here and I do not want to pretend otherwise. Naming one cell and locking it makes you harder to keep supplied when that cell is the constrained one. Some programs deliberately name a primary plus a pre-approved alternate. That is a legitimate strategy. The point is that the choice gets made on purpose at signature, not discovered during a shortage.

Money, volume, and what you are actually buying

Volume commitments buy capacity. They do not automatically buy allocation priority, and they can buy something else entirely if robot demand falls — take-or-pay exposure on a quantity you committed to when the pipeline looked a lot different.

When a supplier asks for an annual volume commitment as the price of priority, the honest question is which clause the commitment unlocks. Commitment in one section, priority in another, no cross-reference between them — that is the most common structural gap I see. The commitment is real and it lands in the supplier's planning system. The priority is aspirational. You paid in the currency that hurts and received the currency that does not.

Prepayment and deposits work the same way. Suppliers do ask for money up front, and sometimes it genuinely goes toward reserving cells or buying tooling. But if cash is moving, the priority language should live in the same clause as the payment, with a defined outcome if the tier is not honored. Money in one place and a soft effort clause in another is not a deal; it is a transfer.

Shortage, force majeure, and the exit you thought you had

Read the shortage clause for the method, not the promise. When there are not enough cells to go around, the supplier will divide the supply somehow. Pro rata across forecast? Pro rata across historical purchases? First-come by order date? A flat percentage reduction applied to everyone equally? Each of those produces a completely different outcome for you, and the clause either names the method or leaves the supplier to invent it in the moment. A shortage allocation clause should state the method the supplier uses to divide limited cells among customers, and if it does not, you are negotiating that method after you have lost your leverage.

Then go find the force majeure section and read what it excuses. Cell shortage language is often drafted broadly enough that a supplier's inability to obtain materials sits inside it. If the clause that would normally give you a remedy for a shortfall is excused by the clause above it, the remedy is decoration.

Which brings up termination. If allocation gets cut and stays cut, can you exit without penalty, and on what trigger? A delivered percentage of forecast below a defined threshold, sustained over a defined period, is a trigger that means something. So is a wind-down path: last-time-buy rights, tail supply, spares for the units already in your fleet. Buyers spend their energy on entry terms and forget that the exit is also a supply-continuity clause.

Remedies a plant manager can actually use

A remedy should be something a plant manager can execute on a Tuesday afternoon. Expedited freight at the supplier's cost. A defined substitute cell with buyer approval. A right to buy cells directly from the cell manufacturer, or to pull against the supplier's own allocation, when the pack assembler cannot deliver. Priority in the next quarter's true-up. Access to the assembler's reserved inventory for service spares.

If the remedy is a credit note, it protects the balance sheet and not the fleet. Robots sitting idle because packs are not shipping do not care about a rebate.

The disclosure question

Last piece: does the agreement require the supplier to tell you anything? Some buyers now ask pack assemblers to disclose their own cell supply agreements, or at minimum to disclose the existence of allocation risk. Full disclosure is frequently refused, and not unreasonably — those terms are commercially sensitive and cell makers are not enthusiastic about them circulating. An attestation, a redacted statement, or a notification obligation can be the workable middle: supplier must notify buyer within a set number of business days after receiving notice that its own cell allocation has been reduced.

That notification is worth more than it looks. It gives you weeks to start a second-source qualification, place a bridge buy, or warn your own customers. The alternative is finding out when the shipping schedule goes empty.

What I mark up

The whole review fits on one page. Cell manufacturer and part number at the top. Then, for every clause in the document, one question: does this clause name the cell, define the priority tier, state how the supplier must treat the forecast, describe the method for rationing a shortage, or give me a remedy I can use? Five questions. A clause that answers none of them is not an allocation clause, no matter how reassuring it reads on the first pass.

Signature is the last moment the buyer has leverage. After that, the agreement is what it says — and what it says is what the planner will do when the constraint finally arrives.